197
Participants
Start Date
December 22, 2021
Primary Completion Date
April 30, 2028
Study Completion Date
July 31, 2028
E2814
Administered intravenously in a blinded fashion
Lecanemab
Administered intravenously
Matching Placebo (E2814)
Placebo administered intravenously in a blinded fashion.
Neuroscience Research Australia, Randwick
Mental Health Research Institute, Melbourne
Hospital Clínic I Provincial de Barcelona, Barcelona
Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico City
University of Pittsburgh, Pittsburgh
IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia
Emory University, Atlanta
CHU de Toulouse - Hôpital Purpan, Toulouse
University of Alabama in Birmingham, Birmingham
Indiana University School of Medicine, Indianapolis
Azienda Ospedaliera Universitaria Careggi, Florence
Hopital Roger Salengro - CHU Lille, Lille
Advocate Lutheran General Hospital, Park Ridge
Washington University in St. Louis, St Louis
Groupe Hospitalier Pitie-Salpetriere, Paris
Hopital Neurologique Pierre Wertheimer, Bron
Universitaetsklinikum Tubingen, Tübingen
Kerwin Research Center,, Dallas
CHU de Rouen - Hôpital Charles Nicolle, Rouen
LMU-Campus Grosshadern, Munich
USC Keck School of Medicine, Los Angeles
University of California San Diego Medical Center, La Jolla
University of Washington, Seattle
Yale University School of Medicine, New Haven
Butler Hospital, Providence
Instituto de Investigaciones Neurologicas Raul Carrea, FLENI, Ciudad Autonoma de Buenos Aire
Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo
UBC Hospital, Vancouver
Sunnybrook Health Sciences Centre, Toronto
McGill Center for Studies in Aging, Verdun
CHU de Quebec - Hôpital de l' Enfant Jésus, Québec
Grupo de Neurociencias Sede de la Universidad de Antioquia, Medellín
St Vincent's University Hospital, Dublin
Niigata University Medical & Dental Hospital, Niigata
University of Tokyo Hospital, Bunkyō City
Brain Research Center, Amsterdam
University of Puerto Rico, School of Medicine, San Juan
The National Hospital for Neurology and Neurosurgery, London
Alzheimer's Association
OTHER
National Institute on Aging (NIA)
NIH
Accelerating Medicines Partnership (AMP)
OTHER
Eisai Inc.
INDUSTRY
Washington University School of Medicine
OTHER